Christopher Kniese1, Khalil Diab2, Marwan Ghabril3, Gabriel Bosslet2. 1. Department of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN. Electronic address: cmkniese@iupui.edu. 2. Department of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN. 3. Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN.
Abstract
BACKGROUND: Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular intrahepatic portosystemic shunt and liver transplantation may be required. Previously, indwelling tube drainage has been avoided due to concerns regarding high complication rates and overall poor outcomes. Recently, indwelling pleural catheters (IPCs) have been proposed as a novel treatment option for HH. METHODS: This study was a retrospective review of patients who had undergone IPC placement for HH over a 10-year period at a large liver transplant referral center. We tracked outcomes, including complication rates and liver transplantation, as well as biomarkers of nutritional status. RESULTS: Sixty-two patients underwent IPC placement between 2007 and 2017, with 33 IPCs (53%) placed as a bridge to liver transplantation. Complications were recorded in 22 patients (36%); empyema was the most common, diagnosed in 10 patients (16.1%). Ten patients evaluated for liver transplantation underwent successful transplantation following IPC placement. There were statistically significant decreases in both BMI and serum albumin levels following IPC placement. CONCLUSIONS: IPCs represent a potential treatment for refractory HH and should be used with caution in patients eligible for liver transplantation. Ideally, IPC use for these patients would be evaluated by a multidisciplinary team. IPC use may lead to small decreases in BMI and serum albumin levels in patients over time.
BACKGROUND: Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular intrahepatic portosystemic shunt and liver transplantation may be required. Previously, indwelling tube drainage has been avoided due to concerns regarding high complication rates and overall poor outcomes. Recently, indwelling pleural catheters (IPCs) have been proposed as a novel treatment option for HH. METHODS: This study was a retrospective review of patients who had undergone IPC placement for HH over a 10-year period at a large liver transplant referral center. We tracked outcomes, including complication rates and liver transplantation, as well as biomarkers of nutritional status. RESULTS: Sixty-two patients underwent IPC placement between 2007 and 2017, with 33 IPCs (53%) placed as a bridge to liver transplantation. Complications were recorded in 22 patients (36%); empyema was the most common, diagnosed in 10 patients (16.1%). Ten patients evaluated for liver transplantation underwent successful transplantation following IPC placement. There were statistically significant decreases in both BMI and serum albumin levels following IPC placement. CONCLUSIONS: IPCs represent a potential treatment for refractory HH and should be used with caution in patients eligible for liver transplantation. Ideally, IPC use for these patients would be evaluated by a multidisciplinary team. IPC use may lead to small decreases in BMI and serum albumin levels in patients over time.
Authors: Xavier Xiol; Gemma Tremosa; Jose Castellote; Joan Gornals; Carmen Lama; Carmen Lopez; Joan Figueras Journal: Transpl Int Date: 2005-06 Impact factor: 3.782
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Momen M Wahidi; Chakravarthy Reddy; Lonny Yarmus; David Feller-Kopman; Ali Musani; R Wesley Shepherd; Hans Lee; Rabih Bechara; Carla Lamb; Scott Shofer; Kamran Mahmood; Gaetane Michaud; Jonathan Puchalski; Samaan Rafeq; Stephen M Cattaneo; John Mullon; Steven Leh; Martin Mayse; Samantha M Thomas; Bercedis Peterson; Richard W Light Journal: Am J Respir Crit Care Med Date: 2017-04-15 Impact factor: 21.405
Authors: Edward T H Fysh; Alain Tremblay; David Feller-Kopman; Eleanor K Mishra; Mark Slade; Luke Garske; Amelia O Clive; Carla Lamb; Rogier Boshuizen; Benjamin J Ng; Andrew W Rosenstengel; Lonny Yarmus; Najib M Rahman; Nick A Maskell; Y C Gary Lee Journal: Chest Date: 2013-11 Impact factor: 9.410
Authors: Rahul Bhatnagar; Elaine D Reid; John P Corcoran; Jessamy D Bagenal; Sandra Pope; Amelia O Clive; Natalie Zahan-Evans; Peter O Froeschle; Douglas West; Najib M Rahman; Sumit Chatterji; Pasupathy R Sivasothy; Nick A Maskell Journal: Thorax Date: 2013-12-16 Impact factor: 9.139
Authors: Yan S Kim; Irawan Susanto; Catherine A Lazar; Ali Zarrinpar; Patricia Eshaghian; M Iain Smith; Ronald Busuttil; Tisha S Wang Journal: BMC Pulm Med Date: 2012-12-17 Impact factor: 3.317
Authors: Samira Shojaee; Najib Rahman; Kevin Haas; Ryan Kern; Michael Leise; Mohammed Alnijoumi; Carla Lamb; Adnan Majid; Jason Akulian; Fabien Maldonado; Hans Lee; Marwah Khalid; Todd Stravitz; Le Kang; Alexander Chen Journal: Chest Date: 2018-08-29 Impact factor: 9.410
Authors: Karim T Osman; Ahmed M Abdelfattah; Syed K Mahmood; Lina Elkhabiry; Fredric D Gordon; Amir A Qamar Journal: Dig Dis Sci Date: 2022-05-09 Impact factor: 3.487